Acurx Pharmaceuticals, Inc. (ACXP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Acurx Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.47x | -0.98x | -3.33x | -3.56x | -3.46x | -17.01x |
| P/B Ratio | 0.71x | 22.54x | 10.40x | 5.88x | 3.56x | 28.96x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.18x | 1.19x | 2.53x | 4.55x | 15.71x | 6.82x |
| Quick Ratio | 3.18x | 1.19x | 2.53x | 4.55x | 15.71x | 6.82x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x |
YoY = year-over-year change. Source: FMP..